Nimotuzumab combined with radiotherapy for the treatment of hypopharyngeal cancer - A case report from a tertiary cancer center

BACKGROUND: Nimotuzumab is a monoclonal antibody against epidermal growth factor receptor which can be combined with chemotherapy and radiotherapy for the treatment of locally advanced unresectable squamous cell carcinoma of head-and-neck region and its role has already been established in India. AI...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarajan, Aswin, Sakthivelu, Arun, Santhanaraman, Narendran, Ravichandar, Ramya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2021
Materias:
Technical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177838/
https://www.ncbi.nlm.nih.gov/pubmed/34104833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177838/
https://www.ncbi.nlm.nih.gov/pubmed/34104833

Ejemplares similares